134 related articles for article (PubMed ID: 17428628)
1. Molecular interactions between dimethoxycurcumin and Pamam dendrimer carriers.
Markatou E; Gionis V; Chryssikos GD; Hatziantoniou S; Georgopoulos A; Demetzos C
Int J Pharm; 2007 Jul; 339(1-2):231-6. PubMed ID: 17428628
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of polyamidoamine (PAMAM) dendrimers as drug carriers of anti-bacterial drugs using sulfamethoxazole (SMZ) as a model drug.
Ma M; Cheng Y; Xu Z; Xu P; Qu H; Fang Y; Xu T; Wen L
Eur J Med Chem; 2007 Jan; 42(1):93-8. PubMed ID: 17095123
[TBL] [Abstract][Full Text] [Related]
3. Bundling and aggregation of DNA by cationic dendrimers.
Froehlich E; Mandeville JS; Weinert CM; Kreplak L; Tajmir-Riahi HA
Biomacromolecules; 2011 Feb; 12(2):511-7. PubMed ID: 21192723
[TBL] [Abstract][Full Text] [Related]
4. Incorporation of dimethoxycurcumin into charged liposomes and the formation kinetics of fractal aggregates of uncharged vectors.
Hadjidemetriou M; Pippa N; Pispas S; Demetzos C
J Liposome Res; 2013 Jun; 23(2):94-100. PubMed ID: 23294394
[TBL] [Abstract][Full Text] [Related]
5. PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality.
Majoros IJ; Myc A; Thomas T; Mehta CB; Baker JR
Biomacromolecules; 2006 Feb; 7(2):572-9. PubMed ID: 16471932
[TBL] [Abstract][Full Text] [Related]
6. Dendrimers as potential drug carriers. Part I. Solubilization of non-steroidal anti-inflammatory drugs in the presence of polyamidoamine dendrimers.
Yiyun C; Tongwen X
Eur J Med Chem; 2005 Nov; 40(11):1188-92. PubMed ID: 16153746
[TBL] [Abstract][Full Text] [Related]
7. Solubility of nicotinic acid in polyamidoamine dendrimer solutions.
Yiyun C; Tongwen X
Eur J Med Chem; 2005 Dec; 40(12):1384-9. PubMed ID: 16226352
[TBL] [Abstract][Full Text] [Related]
8. Dendrimers bind human serum albumin.
Froehlich E; Mandeville JS; Jennings CJ; Sedaghat-Herati R; Tajmir-Riahi HA
J Phys Chem B; 2009 May; 113(19):6986-93. PubMed ID: 19382803
[TBL] [Abstract][Full Text] [Related]
9. Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex.
Patri AK; Kukowska-Latallo JF; Baker JR
Adv Drug Deliv Rev; 2005 Dec; 57(15):2203-14. PubMed ID: 16290254
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of monofunctional curcumin derivatives, clicked curcumin dimer, and a PAMAM dendrimer curcumin conjugate for therapeutic applications.
Shi W; Dolai S; Rizk S; Hussain A; Tariq H; Averick S; L'Amoreaux W; El ldrissi A; Banerjee P; Raja K
Org Lett; 2007 Dec; 9(26):5461-4. PubMed ID: 18020348
[TBL] [Abstract][Full Text] [Related]
11. Kinetic and equilibrium binding analysis of protein-ligand interactions at poly(amidoamine) dendrimer monolayers.
Hong MY; Lee D; Kim HS
Anal Chem; 2005 Nov; 77(22):7326-34. PubMed ID: 16285682
[TBL] [Abstract][Full Text] [Related]
12. Amine functionalization of cholecyst-derived extracellular matrix with generation 1 PAMAM dendrimer.
Chan JC; Burugapalli K; Naik H; Kelly JL; Pandit A
Biomacromolecules; 2008 Feb; 9(2):528-36. PubMed ID: 18198835
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin-PAMAM dendrimer complex attached to liposomes: cytotoxic studies against human cancer cell lines.
Papagiannaros A; Dimas K; Papaioannou GT; Demetzos C
Int J Pharm; 2005 Sep; 302(1-2):29-38. PubMed ID: 16099117
[TBL] [Abstract][Full Text] [Related]
14. Transepithelial and endothelial transport of poly (amidoamine) dendrimers.
Kitchens KM; El-Sayed ME; Ghandehari H
Adv Drug Deliv Rev; 2005 Dec; 57(15):2163-76. PubMed ID: 16289433
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the aqueous solubilization of practically insoluble niclosamide by polyamidoamine (PAMAM) dendrimers and cyclodextrins.
Devarakonda B; Hill RA; Liebenberg W; Brits M; de Villiers MM
Int J Pharm; 2005 Nov; 304(1-2):193-209. PubMed ID: 16198076
[TBL] [Abstract][Full Text] [Related]
16. Enhancing amine terminals in an amine-deprived collagen matrix.
Tiong WH; Damodaran G; Naik H; Kelly JL; Pandit A
Langmuir; 2008 Oct; 24(20):11752-61. PubMed ID: 18774827
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic and pharmacodynamic studies of poly(amidoamine) dendrimer based simvastatin oral formulations for the treatment of hypercholesterolemia.
Kulhari H; Kulhari DP; Prajapati SK; Chauhan AS
Mol Pharm; 2013 Jul; 10(7):2528-33. PubMed ID: 23692066
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and assessment of first-generation polyamidoamine dendrimer prodrugs to enhance the cellular permeability of P-gp substrates.
Najlah M; Freeman S; Attwood D; D'Emanuele A
Bioconjug Chem; 2007; 18(3):937-46. PubMed ID: 17355118
[TBL] [Abstract][Full Text] [Related]
19. Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy.
Majoros IJ; Thomas TP; Mehta CB; Baker JR
J Med Chem; 2005 Sep; 48(19):5892-9. PubMed ID: 16161993
[TBL] [Abstract][Full Text] [Related]
20. Polyamidoamine dendrimers used as solubility enhancers of ketoprofen.
Yiyun C; Tongwen X; Rongqiang F
Eur J Med Chem; 2005 Dec; 40(12):1390-3. PubMed ID: 16226353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
